Independence Blue Cross reissued MA08.094c (Voretigene Neparvovec-rzyl/Luxturna®) with NO SUBSTANTIVE CHANGES on 04/01/2026 as part of their annual review process. This is an informational reissue only; all coverage criteria, medical necessity requirements, and billing codes remain unchanged from the 01/01/2024 effective version.
Get alerts when payers change rules like this one
We check Independence Blue Cross and other payers every day and email you when a change matches your specialty and state.
Summaries are AI-assisted. Always confirm against the original payer notice.
What is PolicyChanges
One workspace for payer rules, prior auth, coding and compliance
Medical practices use PolicyChanges to catch payer changes before they cause denials. Every change is summarized in plain English, with the codes involved, the date it takes effect and what to do.